Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keverprazan vs vonoprazan dual therapy for Helicobacter pylori eradication
ChiCTR2500107735Phase 4Not yet recruiting
- Sponsor
- Eighth Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Helicobacter pylori infection comparing Keverprazan + amoxicillin with Vonoprazan + amoxicillin (2 arms). Primary endpoints: Helicobacter pylori eradication rate, Blood routine and liver function and 1 more. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
keverprazanvonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500107735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107735.